364 related articles for article (PubMed ID: 32091339)
41. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.
Wang XM; Walitt B; Saligan L; Tiwari AF; Cheung CW; Zhang ZJ
Cytokine; 2015 Mar; 72(1):86-96. PubMed ID: 25573802
[TBL] [Abstract][Full Text] [Related]
42. PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats.
Jiang ZG; Winocur G; Wojtowicz JM; Shevtsova O; Fuller S; Ghanbari HA
PLoS One; 2018; 13(1):e0191866. PubMed ID: 29370277
[TBL] [Abstract][Full Text] [Related]
43. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.
Boykoff N; Moieni M; Subramanian SK
J Cancer Surviv; 2009 Dec; 3(4):223-32. PubMed ID: 19760150
[TBL] [Abstract][Full Text] [Related]
44. Cognitive impairment and chemotherapy: a brief overview.
Vitali M; Ripamonti CI; Roila F; Proto C; Signorelli D; Imbimbo M; Corrao G; Brissa A; Rosaria G; de Braud F; Garassino MC; Lo Russo G
Crit Rev Oncol Hematol; 2017 Oct; 118():7-14. PubMed ID: 28917271
[TBL] [Abstract][Full Text] [Related]
45. Dietary agents in mitigating chemotherapy-related cognitive impairment (chemobrain or chemofog): first review addressing the benefits, gaps, challenges and ways forward.
Raghu SV; Kudva AK; Rao S; Prasad K; Mudgal J; Baliga MS
Food Funct; 2021 Nov; 12(22):11132-11153. PubMed ID: 34704580
[TBL] [Abstract][Full Text] [Related]
46. Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.
Onzi GR; D'Agustini N; Garcia SC; Guterres SS; Pohlmann PR; Rosa DD; Pohlmann AR
Drug Saf; 2022 Jun; 45(6):601-621. PubMed ID: 35606623
[TBL] [Abstract][Full Text] [Related]
47. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A
Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298
[TBL] [Abstract][Full Text] [Related]
48. Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus.
Bagnall-Moreau C; Chaudhry S; Salas-Ramirez K; Ahles T; Hubbard K
Mol Neurobiol; 2019 Oct; 56(10):7159-7172. PubMed ID: 30989632
[TBL] [Abstract][Full Text] [Related]
49. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
[TBL] [Abstract][Full Text] [Related]
50. Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection.
Shi DD; Dong CM; Ho LC; Lam CTW; Zhou XD; Wu EX; Zhou ZJ; Wang XM; Zhang ZJ
Neurobiol Dis; 2018 Jun; 114():164-173. PubMed ID: 29534932
[TBL] [Abstract][Full Text] [Related]
51. Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats.
Shaker FH; El-Derany MO; Wahdan SA; El-Demerdash E; El-Mesallamy HO
Life Sci; 2021 Mar; 269():119078. PubMed ID: 33460662
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy and cognitive impairment: An animal model approach.
Winocur G
Can J Exp Psychol; 2017 Dec; 71(4):265-273. PubMed ID: 29215907
[TBL] [Abstract][Full Text] [Related]
53. Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer.
Rodríguez Martín B; Fernández Rodríguez EJ; Rihuete Galve MI; Cruz Hernández JJ
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33265966
[TBL] [Abstract][Full Text] [Related]
54. Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer.
Winocur G; Berman H; Nguyen M; Binns MA; Henkelman M; van Eede M; Piquette-Miller M; Sekeres MJ; Wojtowicz JM; Yu J; Zhang H; Tannock IF
Neuroscience; 2018 Jan; 369():51-65. PubMed ID: 29113931
[TBL] [Abstract][Full Text] [Related]
55. Role of omega 3 fatty acid in chemo-therapy induced cognitive decline.
Shahid A; Jameel H; Nousheen H
J Pak Med Assoc; 2021 Feb; 71(2(A)):575. PubMed ID: 33819259
[No Abstract] [Full Text] [Related]
56. Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.
Ma J; Huo X; Jarpe MB; Kavelaars A; Heijnen CJ
Acta Neuropathol Commun; 2018 Oct; 6(1):103. PubMed ID: 30270813
[TBL] [Abstract][Full Text] [Related]
57. [Chemobrain].
Szentmartoni G; Makkos Z; Dank M
Neuropsychopharmacol Hung; 2018 Sep; 20(3):112-116. PubMed ID: 30459288
[TBL] [Abstract][Full Text] [Related]
58. Protective effects of cerebrolysin against chemotherapy (carmustine) induced cognitive impairment in Albino mice.
Sharma S; Raj K; Singh S
Drug Chem Toxicol; 2022 Nov; 45(6):2769-2779. PubMed ID: 34674598
[TBL] [Abstract][Full Text] [Related]
59. "Chemobrain" in childhood cancer survivors-the impact on social, academic, and daily living skills: a qualitative systematic review.
Semendric I; Pollock D; Haller OJ; George RP; Collins-Praino LE; Whittaker AL
Support Care Cancer; 2023 Aug; 31(9):532. PubMed ID: 37606711
[TBL] [Abstract][Full Text] [Related]
60. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
